Wedbush Upgrades Edwards Lifesciences (EW) to Neutral; Solid Q1:2011 Results Beat Expectations
Tweet Send to a Friend
Wedbush upgraded Edwards Lifesciences (NYSE: EW) from Underperform to Neutral. PT increasd from $75 to $78.
Wedbush analyst says, "Our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
